Software, Data, and Services for Pharmaceutical Research
CSD data and software guide, inform and reduce risks at every stage for top pharmaceutical companies around the world, including Pfizer, Roche, AstraZeneca, Bristol Myers-Squibb and many more.
From target validation, to hit identification, lead optimization, solid form selection, formulation, and manufacturing, CSD data and software supports your drug development journey.
Examples of CSD data and software in use to discover, develop, and formulate pharmaceuticals from the scientific literature.
Roche Pharmaceutical Research and Early Development
“The breadth and depth of CSD data is enormous today. It covers a lot of space of interest to medicinal chemistry. Plus, you know that every structure you see has been derived from experiment. This leads to very high confidence in predictions based on CSD data, whether you predict a conformation or piece together a new structure from components.”
Dr Martin Stahl, Head of Lead Discovery
MRL, Merck & Co.
“The use of the Cambridge Structural Database (CSD) and of the CCDC software to analyse the data provided an invaluable resource to enable an understanding of the applicability of CSP for predicting solvate formation of drug candidates.”
Dr Luca Iuzzolino, Senior Scientist in Computational Chemistry
Novartis Institutes for Biomedical Research
“It’s clear that the arsenal of intra- and inter-moleuclar interactions available to medicinal chemists is still evolving, as is our understanding of how to best take advantage of them.”
Dr Brian Hurley, Senior Principal Scientist for Global Discovery Chemistry